Analyst Ratings January 29, 2026

Evercore Lifts Meta Platforms Price Target to $900, Cites AI-Driven Revenue Inflection

Analysts raise targets after stronger-than-expected quarterly results and robust guidance, spotlighting ad recovery and heavy capex for AI ambitions

By Leila Farooq META
Evercore Lifts Meta Platforms Price Target to $900, Cites AI-Driven Revenue Inflection
META

Evercore ISI raised its price objective on Meta Platforms Inc. (NASDAQ: META) to $900 from $875 and kept an Outperform rating, reflecting a bullish view tied to AI-related revenue prospects and recent quarterly beats. The adjustment sits alongside a market consensus that rates the stock as a strong buy and follows Meta's better-than-expected fourth-quarter results and accelerated first-quarter revenue outlook.

Key Points

  • Evercore ISI raised its price target on Meta to $900 from $875 and maintained an Outperform rating, based on a 25x multiple of its 2027 EPS estimate of $36.
  • InvestingPro data shows a strong buy consensus rating of 1.33 for Meta, with some analysts projecting targets as high as $1,117; the new Evercore target implies about 25% upside.
  • Meta reported Q4 2025 EPS of $8.88 versus $8.19 expected and revenue of $59.9 billion versus $58.35 billion expected; the company projected aggressive FY2026 capex growth of approximately $55 billion and total expenditure growth of approximately 40%.

Evercore ISI has increased its price target for Meta Platforms Inc. to $900 from $875 while maintaining an Outperform recommendation on the shares. The change is calibrated against Evercore’s model that applies a multiple of 25 to its 2027 earnings per share estimate of $36, yielding the new target.

According to InvestingPro data cited alongside the research move, Meta carries a strong buy consensus rating of 1.33, with some of the most optimistic analysts placing targets as high as $1,117. Evercore’s lift to $900 implies roughly a 25% upside from the current market price, based on the firm’s stated assumptions.

Market valuation metrics highlighted in the accompanying analysis show Meta trading at a price-to-earnings ratio of 29.65 and commanding an approximate enterprise value of $1.69 trillion. InvestingPro’s Fair Value model indicates that, by its methodology, the stock is fairly valued at present.

Evercore’s revision followed Meta’s fourth-quarter performance, which topped expectations, and management’s first-quarter revenue outlook that outpaced estimates. The company signaled a 7-point acceleration to about 30% year-over-year revenue growth on an ex-FX basis for the first quarter, a pace that drew analyst attention.

Profitability remains strong by several measures: InvestingPro data shows Meta retaining gross profit margins of 82.01%.

Separately, Meta provided ambitious fiscal year 2026 capital spending guidance, forecasting capex growth of approximately $55 billion and total expenditure expansion of approximately 40%. Evercore observers interpreted the guidance as consistent with management’s push to lead in artificial intelligence, noting that the firm’s model implies a roughly $50 billion revenue step-up in 2026 that supports an "AI-driven revenue inflection point." That characterization aligns with management’s stated objective to be an AI leader.

Meta’s reported fourth-quarter 2025 financials reinforced the bullish analyst response. The company posted earnings per share of $8.88, beating the consensus forecast of $8.19, and reported revenue of $59.9 billion versus an expected $58.35 billion.

In the wake of those results, multiple research firms adjusted their price targets. Canaccord Genuity raised its target to $930 while keeping a Buy rating and cited growth in advertising revenue. DA Davidson lifted its target to $850 after noting that Meta beat both revenue and earnings projections. Truist Securities increased its target to $900 and retained a Buy rating, pointing to Meta’s strong first-quarter guidance that projects growth of about 30%. Oppenheimer, by contrast, reiterated a Perform rating and described Meta’s fundamentals as at peak levels, attributing that strength to AI-enhanced engagement and new product introductions.

Collectively, the analyst moves and company disclosures signal that investors and strategists are weighing a combination of robust top-line momentum, sizable near-term investment, and AI-related revenue potential when reassessing Meta’s outlook.


Context and implications

The series of target changes and the posture from Evercore emphasize three themes evident in the data: solid recent operating performance, a step-up in projected investment for 2026, and an expectation that AI initiatives will materially influence revenue. These elements are central to how research firms are re-evaluating Meta’s valuation and growth trajectory.

Risks

  • High projected capital expenditures - Meta’s guidance for approximately $55 billion in capex growth and about 40% total expenditure growth for FY2026 increases execution and financing risk for the company and could pressure margins if investments do not yield expected revenue gains.
  • Valuation sensitivity - With the stock trading at a P/E of 29.65 and an implied market value near $1.69 trillion, future returns are sensitive to earnings execution; any slowdown versus the analyst assumptions could affect market sentiment.
  • Dependence on AI-driven revenue assumptions - Evercore’s thesis includes an implied roughly $50 billion revenue step-up in 2026 that reflects an "AI-driven revenue inflection point"; if AI initiatives do not materialize into the anticipated revenue, projected upside could be at risk.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026